Biomerica Historical Financial Ratios
| BMRA Stock | USD 0.32 0.02 6.67% |
Biomerica is presently reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.3 or Days Sales Outstanding of 71.39 will help investors to properly organize and evaluate Biomerica financial condition quickly.
Biomerica |
About Biomerica Financial Ratios Analysis
BiomericaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Biomerica investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Biomerica financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Biomerica history.
Biomerica Financial Ratios Chart
Add Fundamental
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Ev To Free Cash Flow
A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.Most ratios from Biomerica's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.At present, Biomerica's Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 2.30, whereas Book Value Per Share is forecasted to decline to 0.37.
| 2021 | 2022 | 2023 (projected) | Days Sales Outstanding | 14.97 | 49.36 | 63.83 | PTB Ratio | 5.33 | 1.65 | 1.48 |
Biomerica fundamentals Correlations
Click cells to compare fundamentals
Biomerica Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biomerica fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 9.65 | 6.05 | 2.35 | 3.63 | 1.8 | 2.74 | |
| Ptb Ratio | 5.21 | 4.54 | 4.72 | 5.33 | 1.65 | 1.48 | |
| Days Sales Outstanding | 96.31 | 73.77 | 14.97 | 49.36 | 63.83 | 71.39 | |
| Book Value Per Share | 0.43 | 1.4 | 0.77 | 0.66 | 0.39 | 0.37 | |
| Free Cash Flow Yield | (0.0684) | (0.13) | (0.0147) | (0.29) | (0.56) | (0.53) | |
| Operating Cash Flow Per Share | (0.42) | (0.44) | (0.0379) | (0.39) | (0.32) | (0.3) | |
| Stock Based Compensation To Revenue | 0.0805 | 0.19 | 0.0668 | 0.22 | 0.15 | 0.16 | |
| Capex To Depreciation | 1.05 | 0.3 | 0.79 | 0.29 | 0.22 | 0.31 | |
| Pb Ratio | 5.21 | 4.54 | 4.72 | 5.33 | 1.65 | 1.48 | |
| Ev To Sales | 8.62 | 5.69 | 2.11 | 2.01 | 1.18 | 2.31 | |
| Free Cash Flow Per Share | (0.43) | (0.47) | (0.0514) | (0.39) | (0.33) | (0.31) | |
| Roic | (0.17) | (0.68) | (0.53) | (0.62) | (0.97) | (0.92) | |
| Inventory Turnover | 1.82 | 1.72 | 2.09 | 6.58 | 2.38 | 2.02 | |
| Net Income Per Share | (0.26) | (0.23) | (0.54) | (0.36) | (0.5) | (0.34) | |
| Days Of Inventory On Hand | 211.89 | 174.6 | 55.48 | 153.37 | 180.52 | 138.54 | |
| Payables Turnover | 5.89 | 15.55 | 21.6 | 14.22 | 16.68 | 17.51 | |
| Research And Ddevelopement To Revenue | 0.32 | 0.29 | 0.33 | 0.096 | 0.3 | 0.28 | |
| Capex To Revenue | 0.0178 | 0.0411 | 0.009026 | 0.0146 | 0.0212 | 0.0206 | |
| Pocfratio | (15.02) | (8.29) | (92.31) | (3.54) | (1.82) | (1.91) | |
| Interest Coverage | (51.3K) | (267.0K) | (17.8K) | (170.2) | (195.73) | (205.52) | |
| Capex To Operating Cash Flow | (0.0277) | (0.0563) | (0.35) | (0.0142) | (0.0215) | (0.0225) | |
| Pfcf Ratio | (14.62) | (7.85) | (68.15) | (3.49) | (1.78) | (1.87) | |
| Days Payables Outstanding | 61.94 | 23.47 | 16.9 | 25.66 | 21.88 | 20.79 | |
| Income Quality | 0.94 | 1.84 | 0.81 | 0.11 | 0.77 | 0.9 | |
| Roe | (0.16) | (0.7) | (0.54) | (0.61) | (0.91) | (0.86) | |
| Ev To Operating Cash Flow | (13.43) | (7.8) | (82.86) | (1.96) | (1.19) | (1.25) | |
| Pe Ratio | (27.6) | (6.73) | (9.79) | (2.72) | (1.63) | (1.72) | |
| Return On Tangible Assets | (0.14) | (0.56) | (0.4) | (0.5) | (0.66) | (0.63) | |
| Ev To Free Cash Flow | (13.06) | (7.38) | (61.18) | (1.94) | (1.17) | (1.22) | |
| Earnings Yield | (0.0362) | (0.15) | (0.1) | (0.37) | (0.61) | (0.58) | |
| Intangibles To Total Assets | 0.009772 | 0.0249 | 0.0149 | 0.0114 | 0.0229 | 0.0218 | |
| Net Debt To E B I T D A | 3.02 | 0.37 | 1.15 | 1.28 | 0.56 | 1.0 | |
| Current Ratio | 10.0 | 7.1 | 4.69 | 6.58 | 3.51 | 3.75 | |
| Tangible Book Value Per Share | 1.38 | 0.75 | 0.64 | 0.82 | 0.38 | 0.36 | |
| Receivables Turnover | 3.79 | 4.95 | 24.39 | 7.39 | 5.72 | 5.14 | |
| Graham Number | 1.39 | 1.59 | 2.69 | 3.07 | 2.3 | 1.78 | |
| Shareholders Equity Per Share | 0.43 | 1.4 | 0.77 | 0.66 | 0.39 | 0.76 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.327 | Quarterly Revenue Growth 0.055 | Return On Assets (0.39) | Return On Equity (0.76) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.